schizophrenia pathophysiology Flashcards
what is the pathophysiology of schizophrenia
increased ventricle size
loss of grey and white matter (less oligodendrites that make myelin sheaths)
reduced synaptic connections - dendritic pruning
altered activity at
- pre frontal cortex (decision making/emotion)
- amygdala (emotion)
- hippocampus (memory)
what are the 2 hypothesis for schizophrenia
dopamine and glutamate hypothesis
what is the dopamine hypothesis for schizophrenia
- Over-activity of dopaminergic neurons in mesolimbic pathway
- There is decreased activity in the Mesocortical pathway, which contributes to the negative symptoms of schizophrenia
what are the examples supporting the dopamine hypothesis for schizophrenia
cocaine = dopamine release = psychosis
reserpine = depletes dopamine = reduces psychosis
levodopa = s/e hallucinations - +tive symptoms
what is the glutamate hypothesis for schizophrenia
- Decreased activity at glutamatergic synapses in the pre-frontal cortex
- Reduced NMDAR signalling in post-synaptic neurons
- Explains all of the symptoms of schizophrenia
- Less signalling here = dopamine overactivity
what is the evidence supporting the glutamate hypothesis for schizophrenia
ketamine NMDAR antagonist enhances downstream effect of dopamine
how do antipsychotics work
mainly block D2 R in mesolimbic pathway
what effects do antipsychotics have on the Tuberhypophyseal pathway
hyperprolactinaemia
breast development
amenorrhea
sexual dysfunction
what effects do antipsychotics have on the nigrostriatal pathway
EPSEs
pseudoparkinsonisms
akathisia
dystonia
tardive dyskineasias
what effects do antipsychotics have on the mesocortial pathway
blocking an already deficient pathway
what effects do antipsychotics have on the mesolimbic pathway
reduces reward pathway
how do second generation antipsychotics work
- D2 antagonists and 5HTA antagonists
o Increase dopamine in striatum
o Increase glutamate release in cortical pyramidal cells - Rapidly dissociates from D2 – no EPSEs
- Muscarinic action
o Nigrostriatal pathway has a balance between Ach and DA (when one is disrupted, the other can increase)
what are the S/E of 2nd gen antipsychotics
A1 antagonism - postural hypotension
H1 antagonism - sedation
neuroleptic malignant syndrome
metabolic syndrome
- weight gain
- insulin resistant
- hyperlipidaemia
QT prolongation
neutropenia